![](https://www.innovations-report.com/wp-content/uploads/2013/06/crop-in-fields-300x200.jpg)
![](https://www.innovations-report.com/wp-content/themes/innovation-report-2/assets/dist/img/placeholder-single-thumbnail.png)
The non-invasive, acute or short-time preventive allergy treatment will be administered as aerosol spray, eye drops, or encapsulated for oral administration, ideally before exposure to the allergen. A complex of antibodies directed against pollen/food allergens with a cell-surface molecule prevents allergic inflammation by trappi ng the allergens on the
mucosal surface of the respi ratory tract, the eyes, or the gut.
Further information: PDF
Wissenstransferzentrum Ost (WTZ Ost)
Phone: +43 1 401 60 25 202
Contact
Dr. Michael Hoschitz
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.